MTRC has released a White Paper "Evidence requirements for medical devices in the “New methods” framework in Norway”

Health technology assessment (HTA) framework plays an important role in market access for medical devices in Norway. Since 2013, all innovative technologies must be evaluated under the national “New Methods” (Nye Metoder) framework. It applies to both technologies and specific device brands, guiding coverage decisions by Regional Health Authorities and influencing national clinical guidelines.

This White Paper provides an opportunity to learn about the evidence requirements related to the 'New Methods' framework from the 5 recent med tech assessments in Norway. The review is followed by recommendations on evidence generation and will be useful for medical device manufacturers seeking market access in Norway, as well as HTA professionals and policymakers interested in the Norwegian evaluation framework.

Read more and request a White Paper here.